Please contact us for more information or to learn if you are eligible to participate.
This study is designed to evaluate biomarkers in samples of patients with cancer. In many cases, the investigation is to identify novel markers to create new anti-cancer therapies and companion diagnostics. The biomarkers could be present in plasma, serum, or the tumor tissue itself. In addition, some tumors will be used in a culture environment to determine the efficacy of novel anti-cancer drugs. In addition, some tissues will be mined to isolate, purify, and culture tumor infiltrating lymphocytes, to evaluate immune reactivity in patients.
Dr. Sohail Rao
Type of Trial